Walbert Timothy P's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Jul 30, 2021
- Accession no.
- 0001209191-21-048792
- Filed
- Jul 30, 2021
- Trade date
- Jul 8-30, 2021
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.54M. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walbert Timothy PCIK 0001349376 | Director, Officer (Chairman, President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 | Ordinary Shares | GGiftDisposed | −5,000 | $0.00 | $0 | 845,887 | Direct | |
| Jul 28, 2021 | Ordinary Shares | AGrant or awardAcquired | +34,833 | $0.00 | $0 | 880,720 | Direct | |
| Jul 28, 2021 | Ordinary Shares | FTax withholdingDisposed | −15,432 | $102.50 | −$1,581,780 | 865,288 | Direct | |
| Jul 30, 2021 | Ordinary Shares | SSaleDisposed | −22,566 | $101.65F3 | −$2,293,833.9 | 842,722 | Direct | |
| Jul 30, 2021 | Ordinary Shares | SSaleDisposed | −2,434 | $102.57F4 | −$249,655.38 | 840,288 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | Ordinary Shares | AGrant or awardAcquired | +69,668 | $0.00 | $0 | 69,668 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.09 to $102.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.33 to $102.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.